Early detection of breast cancer using liquid biopsies and microRNAs
Pilot Test for an Early Diagnosis Kit for Breast Cancer Based on Liquid Biopsies
This study is testing a new blood test that looks for specific markers to help find breast cancer early in women over 35 who are going for their yearly check-up.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 364 (estimated) |
| Ages | 35 Years and up |
| Sex | Female |
| Sponsor | Oncoliq US Inc Industry-sponsored |
| Locations | 1 site (El Palomar, Morón, Buenos Aires) |
| Trial ID | NCT06439940 on ClinicalTrials.gov |
What this trial studies
Oncoliq is an innovative test designed for the early detection of breast cancer through the analysis of liquid biopsies and microRNAs. The study aims to enroll 1,000 women over the age of 35 who are attending their annual gynecological check-up, collecting blood samples to test for specific miRNA biomarkers. Machine learning and AI techniques will be employed to analyze mammogram images and improve detection accuracy. The ultimate goal is to enhance early diagnosis, potentially reducing mortality rates and healthcare costs associated with breast cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are women over the age of 35 who are attending their annual gynecological check-up and have no previous cancer diagnosis.
Not a fit: Patients with a personal history of cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this test could significantly improve early breast cancer detection, leading to better patient outcomes.
How similar studies have performed: Other studies utilizing liquid biopsies and microRNA analysis for cancer detection have shown promising results, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 35 years old who visit the gynecological clinic for their annual mammographic check-up Exclusion Criteria: * Personal history of cancer
Where this trial is running
El Palomar, Morón, Buenos Aires
- Hospital Nacional Profesor Alejandro Posadas — El Palomar, Morón, Buenos Aires, Argentina (Recruiting)
Study contacts
- Study coordinator: Javier Stigliano, MD specialist in mastology
- Email: drstigliano@yahoo.com.ar
- Phone: +54 9 11 5952-7959
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.